Published in World J Surg Oncol on July 13, 2011
Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients. Am J Transplant (2013) 0.81
Expression of hypoxic signaling markers in head and neck squamous cell carcinoma and its clinical significance. Eur Arch Otorhinolaryngol (2014) 0.76
Human Papillomavirus in Kidney Transplant Recipients. Semin Nephrol (2016) 0.75
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med (1988) 9.10
A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med (1992) 5.96
Cancer after kidney transplantation in the United States. Am J Transplant (2004) 5.08
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis (1999) 3.35
Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer (1995) 2.82
Risk of neoplasia in renal transplant patients. Lancet (1995) 2.65
Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer (2003) 2.64
Malignancy after transplantation. Transplantation (2005) 1.92
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ (1989) 1.84
Human papillomavirus infection: biology, epidemiology, and prevention. Int J Gynecol Cancer (2005) 1.74
Cancer incidence among Canadian kidney transplant recipients. Am J Transplant (2007) 1.66
Biotinyl-tyramide-based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical intraepithelial neoplasia. Mod Pathol (2002) 1.51
Post-transplant de novo malignancies in renal transplant recipients: the past and present. Transpl Int (2006) 1.45
Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients. Am J Transplant (2007) 1.37
Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery (1978) 1.32
Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma. J Clin Microbiol (2007) 1.22
Risk factors for malignancy in Japanese renal transplant recipients. Cancer (2007) 1.10
Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol (2001) 1.07
Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet (1986) 1.06
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment. Nephrol Dial Transplant (2002) 1.00
HPV in situ hybridization: impact of different protocols on the detection of integrated HPV. Int J Cancer (2005) 1.00
Early de novo malignancies after kidney transplantation. Transplant Proc (2004) 0.98
Malignancy after kidney transplantation: results of 400 patients from a single center. Clin Transplant (2008) 0.95
Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit Rev Oncol Hematol (2005) 0.95
Human papilloma virus infection and cervical intraepithelial neoplasia in transplanted patients. Transplant Proc (2008) 0.94
Prevalence of HPV DNA in cervical specimens in women with renal transplants: a comparison with dialysis-dependent patients and patients with renal impairment. Nephrol Dial Transplant (1994) 0.93
Managing cancer risk and decision making after kidney transplantation. Am J Transplant (2008) 0.91
Malignancies after renal transplantation: the EDTA-ERA registry experience. European Dialysis and Transplantation Association-European Renal Association. Nephrol Dial Transplant (1995) 0.88
Cancer after transplantation. World J Surg (1986) 0.86
Surveillance of human papilloma virus infection and cervical cancer in kidney transplant recipients: preliminary data. Transplant Proc (2009) 0.84
HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients. Gynecol Oncol (2000) 0.82
Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience. Transpl Int (2009) 0.80
Posttransplant malignancy during 30 years at a single center. Transplant Proc (2000) 0.77
Incidence and clinical behavior of papillary thyroid carcinoma in renal allograft recipients: a single center experience. Transplant Proc (2008) 0.77
HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions. Gynecol Oncol (2003) 1.40
JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin. J Inflamm (Lond) (2008) 1.30
A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections. J Immunol Methods (2005) 1.25
The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein. BMC Cancer (2006) 1.25
Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-κB. Prostate (2010) 1.23
Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicol Appl Pharmacol (2011) 1.19
Diagnosis of early intramural ectopic pregnancy. J Clin Ultrasound (2005) 1.10
Benign metastasizing leiomyoma of the lung. World J Surg Oncol (2013) 1.10
Intracardiac metastasis from known cervical cancer: a case report and literature review. World J Surg Oncol (2013) 1.09
Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis. Clin Cancer Res (2004) 1.07
Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians. Vaccine (2010) 1.04
Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers. J Pathol (2010) 1.04
HCCR-1-interacting molecule "deleted in polyposis 1" plays a tumor-suppressor role in colon carcinogenesis. Gastroenterology (2006) 1.01
Snake venom toxin from Vipera lebetina turanica induces apoptosis of colon cancer cells via upregulation of ROS- and JNK-mediated death receptor expression. BMC Cancer (2012) 1.00
The phosphatidylinositol 3-kinase/Akt pathway regulates the HCCR-1 oncogene expression. Gene (2006) 1.00
Human papillomavirus genotyping by the DNA chip in the cervical neoplasia. DNA Cell Biol (2004) 0.99
Melittin inhibits vascular smooth muscle cell proliferation through induction of apoptosis via suppression of nuclear factor-kappaB and Akt activation and enhancement of apoptotic protein expression. J Pharmacol Exp Ther (2006) 0.98
Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA. Exp Cell Res (2002) 0.96
Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone. Chem Biol Interact (2010) 0.96
The modified chimney technique with a thoracic aortic stent graft to preserve the blood flow of the left common carotid artery for treating descending thoracic aortic aneurysm and dissection. Korean Circ J (2012) 0.95
The increasing frequency of cervical cancer in Korean women under 35. Cancer Res Treat (2008) 0.93
Snake venom toxin inhibits cell growth through induction of apoptosis in neuroblastoma cells. Arch Pharm Res (2009) 0.92
Immunohistochemical analysis of RNA-induced silencing complex-related proteins AGO2 and TNRC6A in prostate and esophageal cancers. APMIS (2010) 0.91
Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery. Gynecol Oncol (2007) 0.91
HCCR-1, a novel oncogene, encodes a mitochondrial outer membrane protein and suppresses the UVC-induced apoptosis. BMC Cell Biol (2007) 0.90
Peptidoglycan enhances secretion of monocyte chemoattractants via multiple signaling pathways. Biochem Biophys Res Commun (2011) 0.89
Establishment of a Korea HPV cohort study. J Gynecol Oncol (2013) 0.89
Adenoma malignum of the uterine cervix: report of four cases. World J Surg Oncol (2013) 0.88
Incidence and risk factors of lower-extremity lymphedema after radical surgery with or without adjuvant radiotherapy in patients with FIGO stage I to stage IIA cervical cancer. Int J Gynecol Cancer (2012) 0.87
Somatic frameshift mutations of bone morphogenic protein receptor 2 gene in gastric and colorectal cancers with microsatellite instability. APMIS (2010) 0.86
Mutational analysis of hypoxia-related genes HIF1alpha and CUL2 in common human cancers. APMIS (2009) 0.85
Clinical analysis of intra-operative frozen section proven borderline tumors of the ovary. J Gynecol Oncol (2009) 0.85
Relationship of serum antioxidant micronutrients and sociodemographic factors to cervical neoplasia: a case-control study. Clin Chem Lab Med (2009) 0.84
ERCC1 (excision repair cross-complementation group 1) expression as a predictor for response of neoadjuvant chemotherapy for FIGO stage 2B uterine cervix cancer. Gynecol Oncol (2010) 0.84
Cell growth inhibition and induction of apoptosis by snake venom toxin in ovarian cancer cell via inactivation of nuclear factor κB and signal transducer and activator of transcription 3. Arch Pharm Res (2012) 0.84
Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression. Cancer Biol Ther (2011) 0.84
A case of advanced gynecologic pelvic tumors showing the diagnostic utility of HPV analysis. J Gynecol Oncol (2009) 0.84
Expression of AIMP1, 2 and 3, the scaffolds for the multi-tRNA synthetase complex, is downregulated in gastric and colorectal cancer. Tumori (2011) 0.83
HPV status in sentinel nodes might be a prognostic factor in cervical cancer. Gynecol Oncol (2007) 0.83
GSTP1 polymorphism, cigarette smoking and cervical cancer risk in Korean women. Yonsei Med J (2002) 0.83
Rectal endometriosis with invasion into lymph nodes. J Obstet Gynaecol Res (2011) 0.83
Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins. Apoptosis (2012) 0.83
Adoptive transfer of human papillomavirus E7-specific CTL enhances tumor chemoresponse through the perforin/granzyme-mediated pathway. Mol Ther (2009) 0.82
Oral progesterone treatment in a young woman with müllerian adenosarcoma whose ovary was preserved: a case report. Int J Gynecol Cancer (2010) 0.82
Large cell neuroendocrine carcinoma of the ovary: a case report and a brief review of the literature. World J Surg Oncol (2014) 0.82
Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer? Int J Gynecol Cancer (2013) 0.81
Duplicated uterine arteries in laparoscopic hysterectomy. J Minim Invasive Gynecol (2008) 0.81
The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women. Gynecol Oncol (2004) 0.81
Methyl gallate and chemicals structurally related to methyl gallate protect human umbilical vein endothelial cells from oxidative stress. Exp Mol Med (2005) 0.81
Laparoscopic upper vaginectomy for post-hysterectomy high risk vaginal intraepithelial neoplasia and superficially invasive vaginal carcinoma. World J Surg Oncol (2013) 0.81
New approaches to pathogenic gene function discovery with human squamous cell cervical carcinoma by gene ontology. Gynecol Oncol (2005) 0.80
Natural compounds,fraxin and chemicals structurally related to fraxin protect cells from oxidative stress. Exp Mol Med (2005) 0.80
Laboratory and clinical aspects of human papillomavirus testing. Crit Rev Clin Lab Sci (2012) 0.80
Asia oceania guidelines for the implementation of programs for cervical cancer prevention and control. J Cancer Epidemiol (2011) 0.80
Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer. J Surg Oncol (2010) 0.79
Clinicopathologic review of ovarian masses in Korean premenarchal girls. Int J Med Sci (2013) 0.79
Adjuvant therapy in high-risk early endometrial carcinoma: a retrospective analysis of 46 cases. J Gynecol Oncol (2008) 0.79
Sequence variation and the transcriptional activity of the upstream regulatory region in human papillomavirus 16 E7 variants in cervical cancer of Korean women. Oncol Rep (2005) 0.79
Interleukin-32β ameliorates metabolic disorder and liver damage in mice fed high-fat diet. Obesity (Silver Spring) (2015) 0.78
The prognostic impact of duration of anemia during chemotherapy in advanced epithelial ovarian cancer. Oncologist (2011) 0.78
Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases. Int J Med Sci (2013) 0.77
Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution. World J Surg Oncol (2011) 0.77
Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16. Int J Gynecol Cancer (2016) 0.77
Enhanced cell growth inhibition by thiacremonone in paclitaxel-treated lung cancer cells. Arch Pharm Res (2015) 0.77
Correlation between immunocytochemistry of human papilloma virus L1 capsid protein and behavior of low-grade cervical cytology in Korean women. J Obstet Gynaecol Res (2011) 0.77
Somatic mutation of GNAQ gene is rare in common solid cancers and leukemias. Acta Oncol (2009) 0.76
Co-culture with NK-92MI cells enhanced the anti-cancer effect of bee venom on NSCLC cells by inactivation of NF-κB. Arch Pharm Res (2014) 0.76
Cell-mediated immune response to human papillomavirus 16 E7 peptide pools in patients with cervical neoplasia. Acta Obstet Gynecol Scand (2011) 0.76
Absence of oncogenic AKT1 E17K mutation in prostate, esophageal, laryngeal and urothelial carcinomas, hepatoblastomas, gastrointestinal stromal tumors and malignant meningiomas. Acta Oncol (2009) 0.76
Barbed versus conventional 2-layer continuous running sutures for laparoscopic vaginal cuff closure. Medicine (Baltimore) (2016) 0.75
CT and MR imaging findings of lymphangioleiomyomatosis involving the uterus and pelvic cavity. Korean J Radiol (2011) 0.75
Application of percutaneous cardiopulmonary support for cardiac tamponade following blunt chest trauma: two case reports. Korean J Thorac Cardiovasc Surg (2012) 0.75
Factors affecting the postoperative mortality in the ruptured abdominal aortic aneurysm. Korean J Thorac Cardiovasc Surg (2012) 0.75
Duodenal perforation caused by an inferior vena cava filter. Korean J Thorac Cardiovasc Surg (2012) 0.75
Cervical adenoid basal carcinoma associated with invasive squamous cell carcinoma: a report of rare co-existence and review of literature. World J Surg Oncol (2011) 0.75
A pilot study to investigate the treatment of cervical human papillomavirus infection with zinc-citrate compound (CIZAR®). Gynecol Oncol (2011) 0.75
A Pilot Study to Investigate the Efficacy of Fibrin Sealant (Tisseel®) in the Loop Electrosurgical Excision Procedure. Gynecol Obstet Invest (2015) 0.75
Effect of Li2O/Al cathode in Alq3 based organic light-emitting diodes. J Nanosci Nanotechnol (2008) 0.75
Incidence and Risk Factors of Lower Extremity Lymphedema After Gynecologic Surgery in Ovarian Cancer. Int J Gynecol Cancer (2016) 0.75